AI-Supported Diagnostics in Perimenopause: Between Hype and Reality

As MIT Technology Review reports (https://www.technologyreview.com/2026/07/17/1140608/theres-a-lot-of-hype-around-perimenopause-dont-buy-it/), perimenopause, the transitional phase before menopause, is currently experiencing increased public attention – not least due to social media and TV doctors. At the same time, more and more companies are trying to market AI technologies for the diagnosis and treatment of this life phase. However, the reality behind the hype is complex.

AI in Perimenopause Diagnostics: Opportunities and Limitations

Artificial intelligence can potentially help by analyzing large amounts of data from blood values, hormone profiles, and symptom recordings to recognize individual patterns and thus support the diagnosis of perimenopause. Especially since the symptoms are very diverse and nonspecific, AI could enable a more objective assessment. However, so far there are no reliable clinical studies that clearly prove the benefit of such AI-supported tools. Many of the applications on the market are based on algorithms trained with limited datasets or rely on subjective information. This leads to uncertainties in diagnosis and can give those affected false reassurance or unnecessarily worry them.

Why Perimenopause Is So Difficult to Pin Down

Perimenopause is not a clearly defined disease but a natural biological process with highly variable symptoms such as hot flashes, sleep disturbances, mood swings, or cycle fluctuations. These symptoms can also have other causes, which complicates diagnosis. In addition, the hormonal adjustment is very individual and takes place over several years. Measuring individual hormones such as FSH (follicle-stimulating hormone) or estrogen alone is not sufficient to determine the exact timing or course of perimenopause. AI models therefore have to integrate very complex data to be able to make reliable statements.

The Influence of Media and Marketing

The increased media attention on perimenopause has led to a boom in products and services promising quick solutions – from dietary supplements to digital health apps. AI is often used as an innovative sales argument, although the scientific basis is often thin. Experts warn that this can lead to misinformation and unsettle women in an already stressful phase of life. Evidence-based advice from specialists and a critical evaluation of AI applications are important.

Why the Topic Remains Relevant

Demographic developments mean that more and more women go through perimenopause and desire better medical care. AI has the potential to enable personalized diagnoses and therapy suggestions if it is based on solid data and transparent algorithms. At the same time, the current situation shows that technological innovations do not automatically guarantee better health solutions. The combination of medical expertise, patient-centered communication, and responsible AI development is crucial to create real added value.

Conclusion

The integration of AI into perimenopause diagnostics is still in its infancy. Despite the hype, users and doctors should know the limits of the technology and rely on well-founded, individual diagnoses. Only in this way can AI contribute in the long term to improving care for women in this life phase without raising false hopes or obscuring risks.